Bruxism
Conditions
Keywords
Bruxism
Brief summary
To investigate the effect of the treatment with Grindcare® on the muscles- and jaw symptoms and at the jaw muscle activity during sleep.
Interventions
Active treatment
Placebo treatment
Sponsors
Study design
Eligibility
Inclusion criteria
* Signed and dated ICF * 18 years or older * Fulfill the RDC-criteria for myofascial TMD diagnose (group 1a or 1b)
Exclusion criteria
* Contraindication of concommitant diseases for the study judged by investigator * Patients who are using occlusal splints in the treatment period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the electromyography (EMG) activity per hour per night | 10 weeks after start of treatment |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of long-term effect of FES on the EMG activity | a 4 weeks period after end og treatment with FES |
Countries
Denmark